Commentary
Providing clinicians with the tools to diagnose and treat the full spectrum of NAFLD will help prevent known complications such as cirrhosis and HCC and improve quality of life for these patients.
This article by T. K. Seen et al. (Icahn School of Medicine, Elmhurst Hospital and Mount Sinai Hospital, USA) discusses the utility of current non-invasive liver function testing in the clinical progression of fatty liver disease along with the imaging modalities that are available.
